The Global Congress on Advanced Vaccine Research and Biotechnology, scheduled for June 15–16, 2026 in Paris, France, serves as an international platform to explore the next era of vaccine science and biotechnology. This congress brings together leading researchers, clinicians, biotechnologists, pharmaceutical experts, and policymakers to share cutting-edge advancements and address the pressing challenges of global immunization and health security.
VaxCon 2026 will cover a wide spectrum of themes, including mRNA technologies, synthetic biology, novel adjuvants, cancer immunotherapy, nanotechnology in vaccine delivery, AI-driven vaccine design, and pandemic preparedness. Through keynote lectures, panel discussions, workshops, and networking sessions, participants will engage in cross-disciplinary dialogue that fosters collaboration between academia, industry, and public health organizations.